Literature DB >> 16714755

Survival and initial chromatid breakage in normal and tumour cells exposed in vitro to gamma rays and carbon ions at the HIRFL.

Y Jianshe1, L Wenjian, J Xiaodong, J Xigang, G Chuanling, W Wei, G Qingxiang.   

Abstract

Human hepatoma and normal liver cells were irradiated with (12)C(6+) ion beams (linear energy transfer (LET) = 96 keV microm(-1)) and gamma-rays at the Heavy Ion Research Facility in Lanzhou (HIRFL). The numbers and types of chromatid breaks were detected using the premature chromosome condensation technique. Irradiation with (12)C(6+) ions produced a majority of isochromatid break types, while chromatid breaks were dominant for irradiation with gamma-rays. Experimental results showed that the initial level of chromatid breaks is clearly related to the absorbed dose from (12)C(6+) ions and gamma-rays. The (12)C(6+) ions are relatively more effective at inducing initial chromatid breaks when compared with the gamma-rays. A relative biological effectiveness (RBE) of about 2.5 resulted for the induction of initial chromatid breaks by (12)C(6+) ions relative to gamma-rays in both cell lines.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16714755     DOI: 10.1259/bjr/99734289

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  6 in total

1.  Premature chromosome condensation technique: A very promising approach to radiotherapy for digestive system cancers.

Authors:  Jian-She Yang
Journal:  World J Gastroenterol       Date:  2006-11-28       Impact factor: 5.742

2.  Treatment regimen design in clinical radiotherapy for hepatoma.

Authors:  Jian-She Yang
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

3.  The differential role of human macrophage in triggering secondary bystander effects after either gamma-ray or carbon beam irradiation.

Authors:  Chen Dong; Mingyuan He; Wenzhi Tu; Teruaki Konishi; Weili Liu; Yuexia Xie; Bingrong Dang; Wenjian Li; Yukio Uchihori; Tom K Hei; Chunlin Shao
Journal:  Cancer Lett       Date:  2015-04-17       Impact factor: 8.679

4.  Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: the PROMETHEUS-01 trial.

Authors:  Stephanie E Combs; Daniel Habermehl; Tom Ganten; Jan Schmidt; Lutz Edler; Iris Burkholder; Oliver Jäkel; Thomas Haberer; Jürgen Debus
Journal:  BMC Cancer       Date:  2011-02-12       Impact factor: 4.430

5.  Evaluation of Threshold Dose of Damaged Hepatic Tissue After Carbon-Ion Radiation Therapy Using Gd-EOB-DTPA-Enhanced Magnetic Resonance Imaging.

Authors:  Masashi Ebara; Kei Shibuya; Hirofumi Shimada; Motohiro Kawashima; Hiromi Hirasawa; Ayako Taketomi-Takahashi; Tatsuya Ohno; Yoshito Tsushima
Journal:  Adv Radiat Oncol       Date:  2021-08-14

6.  Hypofractionated carbon ion therapy delivered with scanned ion beams for patients with hepatocellular carcinoma - feasibility and clinical response.

Authors:  Daniel Habermehl; Jürgen Debus; Tom Ganten; Maria-Katharina Ganten; Julia Bauer; Ingo C Brecht; Stephan Brons; Thomas Haberer; Martin Haertig; Oliver Jäkel; Katia Parodi; Thomas Welzel; Stephanie E Combs
Journal:  Radiat Oncol       Date:  2013-03-13       Impact factor: 3.481

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.